Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 325, Issue 1-2, Pages 131-139Publisher
SPRINGER
DOI: 10.1007/s11010-009-0027-3
Keywords
Leptin; Peroxisome proliferator-activated receptor-gamma; Hepatic stellate cell; Hepatic fibrosis; Nonalcoholic fatty liver disease
Categories
Funding
- Natural Science Fund for College and University in Jiangsu Province [07KJB310094]
- Nantong University
Ask authors/readers for more resources
Compelling evidence indicates the pro-fibrogenic action of leptin in liver. Peroxisome proliferator-activated receptor-gamma (PPAR gamma) can reverse hepatic stellate cell (HSC) activation and maintain HSC quiescence. HSC activation, a key step in the development of liver fibrosis, is coupled with the up-expression of leptin and the dramatic down-expression of PPAR gamma. The present study is aimed to assess the effect of leptin on PPAR gamma gene expression in primary cultured rat HSCs and investigate the related mechanisms by using Western blotting analysis, real-time PCR, transient transfection approach, and cell growth analysis. The results suggest that leptin negatively regulates PPAR gamma gene expression at mRNA level, protein level and PPAR gamma gene promoter activity level in HSCs. The inhibitory effect of leptin on PPAR gamma gene expression contributes to cell growth of activated HSCs in vitro. Phosphatidylinositol 3-kinase/AKT (PI-3 K/AKT) and extracellular signal-regulated kinase (ERK) signaling pathways mediate the leptin-induced inhibition of PPAR gamma gene expression. In summary, these findings suggest that leptin down-regulates PPAR gamma gene expression through activation of PI-3 K/AKT or ERK signaling pathway in primary cultured rat HSCs. Our results might provide novel insights into the mechanisms for the pro-fibrogenic action of leptin in liver.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available